Trial NCT02780128

View at ClinicalTrials.gov 
Org. Study IDs: 14-011071

Last trial update was posted on 2023-11-29

MeSH Interventions

Ceritinib

MeSH Conditions

Neuroblastoma

Other Conditions

Cancer

Stopping Reasons

The goals of Part 1 (molecular screening) were met, but lack of therapies to match molecular aberrations made Part 2 (treatment) no longer feasible.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID